These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15029039)

  • 21. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
    Sall K; Stevenson OD; Mundorf TK; Reis BL
    Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Validation of a questionnaire for the diagnosis of dry eye].
    Donate J; Benítez del Castillo JM; Fernández C; García Sánchez J
    Arch Soc Esp Oftalmol; 2002 Sep; 77(9):493-500. PubMed ID: 12221541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.
    Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG
    Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease.
    Kawakita T; Uchino M; Fukagawa K; Yoshino K; Shimazaki S; Toda I; Tanaka M; Arai H; Sakatani K; Hata S; Okano T; Tsubota K
    Sci Rep; 2016 Feb; 6():20855. PubMed ID: 26865350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
    Hartstein I; Khwarg S; Przydryga J
    Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Carbomer gels in the treatment of dry eye].
    Pouliquen P
    J Fr Ophtalmol; 1999 Oct; 22(8):903-13. PubMed ID: 10572806
    [No Abstract]   [Full Text] [Related]  

  • 28. Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study.
    Amrane M; Creuzot-Garcher C; Robert PY; Ismail D; Garrigue JS; Pisella PJ; Baudouin C
    J Fr Ophtalmol; 2014 Oct; 37(8):589-98. PubMed ID: 25127703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
    Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
    Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of polyacrylic acid (Viscotears) liquid gel versus polyvinylalcohol in the treatment of dry eyes.
    Brodwall J; Alme G; Gedde-Dahl S; Smith J; Lilliedahl NP; Kunz PA; Sunderraj P
    Acta Ophthalmol Scand; 1997 Aug; 75(4):457-61. PubMed ID: 9374260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.
    Semba CP; Torkildsen GL; Lonsdale JD; McLaurin EB; Geffin JA; Mundorf TK; Kennedy KS; Ousler GW
    Am J Ophthalmol; 2012 Jun; 153(6):1050-60.e1. PubMed ID: 22330307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trehalose eye drops in the treatment of dry eye syndrome.
    Matsuo T; Tsuchida Y; Morimoto N
    Ophthalmology; 2002 Nov; 109(11):2024-9. PubMed ID: 12414409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular contact time of a carbomer gel (GelTears) in humans.
    Wilson CG; Zhu YP; Frier M; Rao LS; Gilchrist P; Perkins AC
    Br J Ophthalmol; 1998 Oct; 82(10):1131-4. PubMed ID: 9924298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
    Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
    Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome.
    Chiambaretta F; Doan S; Labetoulle M; Rocher N; Fekih LE; Messaoud R; Khairallah M; Baudouin C;
    Eur J Ophthalmol; 2017 Jan; 27(1):1-9. PubMed ID: 27445067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.
    Brzheskiy VV; Efimova EL; Vorontsova TN; Alekseev VN; Gusarevich OG; Shaidurova KN; Ryabtseva AA; Andryukhina OM; Kamenskikh TG; Sumarokova ES; Miljudin ES; Egorov EA; Lebedev OI; Surov AV; Korol AR; Nasinnyk IO; Bezditko PA; Muzhychuk OP; Vygodin VA; Yani EV; Savchenko AY; Karger EM; Fedorkin ON; Mironov AN; Ostapenko V; Popeko NA; Skulachev VP; Skulachev MV
    Adv Ther; 2015 Dec; 32(12):1263-79. PubMed ID: 26660938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.
    Stevenson D; Tauber J; Reis BL
    Ophthalmology; 2000 May; 107(5):967-74. PubMed ID: 10811092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of 0.5% Carbomer 980 Gel for Treatment of Symptoms of Common Cold: Results of 2 Randomized Trials.
    Dennie L
    Drugs R D; 2019 Jun; 19(2):191-200. PubMed ID: 31004286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
    Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
    Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.
    Donnenfeld ED; Karpecki PM; Majmudar PA; Nichols KK; Raychaudhuri A; Roy M; Semba CP
    Cornea; 2016 Jun; 35(6):741-8. PubMed ID: 27055211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.